These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
592 related articles for article (PubMed ID: 9024793)
1. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin. Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793 [TBL] [Abstract][Full Text] [Related]
2. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554 [TBL] [Abstract][Full Text] [Related]
3. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. Namiki M; Akiyama S; Katagiri T; Suzuki A; Ueno N; Yamaji N; Rosen V; Wozney JM; Suda T J Biol Chem; 1997 Aug; 272(35):22046-52. PubMed ID: 9268344 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells. Figueroa JD; Hayman MJ Exp Cell Res; 2004 Jun; 296(2):163-72. PubMed ID: 15149847 [TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein inhibits differentiation and affects expression of helix-loop-helix regulatory molecules in myoblastic cells. Murray SS; Murray EJ; Glackin CA; Urist MR J Cell Biochem; 1993 Sep; 53(1):51-60. PubMed ID: 7693731 [TBL] [Abstract][Full Text] [Related]
7. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells. Liu LN; Dias P; Houghton PJ Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114 [TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. Katagiri T; Yamaguchi A; Komaki M; Abe E; Takahashi N; Ikeda T; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T J Cell Biol; 1994 Dec; 127(6 Pt 1):1755-66. PubMed ID: 7798324 [TBL] [Abstract][Full Text] [Related]
9. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730 [TBL] [Abstract][Full Text] [Related]
10. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development. Haider SR; Wang W; Kaufman SJ Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852 [TBL] [Abstract][Full Text] [Related]
11. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Akiyama S; Katagiri T; Namiki M; Yamaji N; Yamamoto N; Miyama K; Shibuya H; Ueno N; Wozney JM; Suda T Exp Cell Res; 1997 Sep; 235(2):362-9. PubMed ID: 9299160 [TBL] [Abstract][Full Text] [Related]
12. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1. Grasberger H; Ye H; Mashima H; Bell GI Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981 [TBL] [Abstract][Full Text] [Related]
13. Effect of phase limited inhibition of MyoD expression on the terminal differentiation of bovine myoblasts: no alteration of Myf5 or myogenin expression. Muroya S; Nakajima I; Oe M; Chikuni K Dev Growth Differ; 2005 Sep; 47(7):483-92. PubMed ID: 16179075 [TBL] [Abstract][Full Text] [Related]
14. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases. Kobayashi N; Goto K; Horiguchi K; Nagata M; Kawata M; Miyazawa K; Saitoh M; Miyazono K Genes Cells; 2007 Mar; 12(3):375-85. PubMed ID: 17352741 [TBL] [Abstract][Full Text] [Related]
15. Evidence that E-box promoter elements and MyoD transcription factors play a role in the induction of cathepsin B gene expression during human myoblast differentiation. Jane DT; Morvay LC; Koblinski J; Yan S; Saad FA; Sloane BF; Dufresne MJ Biol Chem; 2002 Dec; 383(12):1833-44. PubMed ID: 12553720 [TBL] [Abstract][Full Text] [Related]
16. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. Valdez MR; Richardson JA; Klein WH; Olson EN Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423 [TBL] [Abstract][Full Text] [Related]
17. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression. Tubaro C; Arcuri C; Giambanco I; Donato R J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein. Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518 [TBL] [Abstract][Full Text] [Related]
19. Exogenous hepatocyte growth factor inhibits myoblast differentiation by inducing myf5 expression and suppressing myoD expression in an organ culture system of embryonic mouse tongue. Yamane A; Amano O; Urushiyama T; Nagata J; Akutsu S; Fukui T; Diekwisch TG Eur J Oral Sci; 2004 Apr; 112(2):177-81. PubMed ID: 15056116 [TBL] [Abstract][Full Text] [Related]
20. Brefeldin A inhibits muscle-specific gene expression during differentiation in C2C12 myoblasts. Ichikawa K; Mimura N; Asano A Exp Cell Res; 1993 Dec; 209(2):333-41. PubMed ID: 8262151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]